Name: TARS Balance Sheet - Tarsus Pharmaceuticals Assets & Debt | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Total Assets, Current Assets, Cash and Equivalents, Total Liabilities, Long-term Debt, Short-term Debt, Shareholders Equity, Working Capital, Book Value Per Share

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

TARS - Tarsus Pharmaceuticals, Inc.

USD | NASDAQ | Healthcare

TARS Balance Sheet - Tarsus Pharmaceuticals Assets & Debt | Ledgeburg

(in millions of USD)	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017
Cash And Short Term Investments
Cash And Equivalents	183.6	94.8	224.9	71.7	171.3	168.1	58.0	-	-
Restricted Cash	0.6	0.0	-	-	0.0	0.0	0.0	-	-
Short Term Investments	233.6	196.6	2.5	145.4	0.5	0.0	-	-	-
Cash And Short Term Investments	417.3	291.4	227.4	217.0	171.8	168.1	58.0	-	-
Receivables
Accounts Receivable	85.1	46.8	16.6	0.0	-	-	-	-	-
Current Assets
Inventory	4.4	2.6	3.1	0.0	-	-	-	-	-
Prepaid Expenses	13.5	14.7	7.9	4.8	4.0
Non-Current Assets
Property, Plant & Equipment Gross	13.8	4.3	2.8	1.5	1.0	0.7	0.2	-	-
Accumulated Depreciation	2.1	2.0	1.3
Current Liabilities
Accounts Payable	16.4	9.4	-	-	-	-	-	-	-
Short Term Debt	-	-	-	-	-
Non-Current Liabilities
Long Term Debt	72.4	71.8	29.8	19.4	0.0	-	-	-	-
Operating Lease Liabilities Non-Current	10.6	0.0	1.5	0.1
Common Equity
Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-	-
Additional Paid In Capital	769.7	584.6	441.6	301.7	213.4
Supplementary Data
Total Debt	72.4	71.8	29.8	19.4	0.0	-	-	-	-
Net debt	(344.8)	(219.5)	(197.6)	(197.6)	(171.8)

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19	Q3 FY 19	Q2 FY 19	Q1 FY 19	Q4 FY 18	Q4 FY 17
Cash And Short Term Investments
Cash And Equivalents	102.2	183.6	112.7	96.6	175.8	94.8	176.2	181.1	193.7	224.9	226.7	106.8	66.0	71.7	169.5

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Current Liabilities
Accounts Payable	24.1	16.4	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Short Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue Current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.0	0.0	0.2
Operating Lease Liabilities Current	0.0	-	0.1	0.3	0.4	0.6	0.6	0.6	0.6	0.4	0.4	0.4	0.7	0.7	0.6	0.6
Accrued Expenses	8.5	17.8	13.6	11.6	9.9	15.8	11.3	8.0	6.0	13.2	7.9	5.3	4.2	5.5	4.1	2.8	1.8	2.8
Other Current Liabilities	32.5	22.2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Current Liabilities	143.5	135.7	117.1	90.3	86.3	80.6	65.9	51.6	42.5	36.9	23.2	14.8	13.3	15.4	14.3

Non-Current Liabilities
Long Term Debt	72.6	72.4	72.3	72.1	72.0	71.8	71.7	71.6	29.9	29.8	29.7	24.6	24.5	19.4	19.4	19.3	19.2	0.0	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Liabilities Non-Current	16.1	-	10.1	0.0	0.0	-	1.2	1.4	1.6	-	1.7	1.8	-	-	0.2	0.3
Deferred Revenue Non-Current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Tax Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Pension Obligations	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Current Liabilities	16.1	10.6	10.1	-	-	0.0	1.2	1.4	1.6	1.7	1.7	1.8	0.0	0.1	0.2	0.3
Total Non-Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	232.2	218.7	199.5	162.4	158.3	152.5	138.8	124.6	74.1	68.5	54.7	41.2	37.8	35.0	33.8	31.3

Common Equity
Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-	-	0.0	-	-	-	-	-
Additional Paid In Capital	782.8	769.7	753.0	738.2	727.7	584.6	574.2	566.1	555.7	441.6	416.4	311.4	305.7	301.7	297.8	294.2	216.1
Retained Earnings	(433.6)	(426.6)	(418.3)	(405.7)	(385.3)	(360.2)	(337.1)	(313.7)	(280.4)	(244.7)	(202.8)	(163.6)	(132.2)	(108.8)	(95.2)	(72.7)	(66.9)
Accumulated Other Comprehensive Income	(0.3)	0.4	0.3	0.0	0.1	0.2	0.3	(0.2)	(0.1)	(0.0)	(0.0)	(0.0)	(0.1)	(0.1)	(0.0)
Treasury Stock	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Stockholders Equity	349.0	343.4	335.1	332.6	342.5	224.5	237.5	252.2	275.2	197.0	213.7	147.7	173.4	192.9	202.6	221.5	149.2
Total Equity	349.0	343.4	335.1	332.6	342.5	224.5	237.5	252.2	275.2	197.0	213.7	147.7	173.4	192.9	202.6	221.5	149.2	166.7

Supplementary Data
Total Debt	72.6	72.4	72.3	72.1	72.0	71.8	71.7	71.6	29.9	29.8	29.7	24.6	24.5	19.4	19.4	19.3	19.2	0.0	-	-	-	-	-	-	-	-	-	-	-	-	-
Net debt	(316.1)	(344.8)	(329.6)	(309.0)	(335.9)	(219.5)	(245.2)	(252.0)	(268.6)	(197.6)	(217.2)	(153.6)	(176.7)	(197.6)	(207.2)	(226.1)	(156.1)	(171.8)
Working Capital	393.7	387.1	384.7	384.2	394.5	276.1	291.2	311.0	298.2	219.2	236.0	168.7	195.4	209.9	219.8	238.6	166.1	164.5
Book Value	349.0	343.4	335.1	332.6	342.5	224.5	237.5	252.2	275.2	197.0	213.7	147.7	173.4	192.9	202.6	221.5	149.2	166.7
Tangible Book Value	341.8	336.1	327.5	324.8	334.4	216.2	228.9	248.6	271.4	193.1	209.7	-	-	192.9	-	-	-

Receivables
Accounts Receivable	100.3	85.1	72.6	58.3	62.4	46.8	29.2	29.5	29.9	16.6	5.4	-	2.5	0.0	0.0	0.0	0.0	0.0	-	20.0	25.0	0.0	-	-	-	-	-	-	-	-	-